(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
---|---|---|---|---|---|---|---|
Turnover | 7.12%9.98B | 28.52%20.21B | 38.67%9.32B | -6.80%15.72B | --6.72B | 55.72%16.87B | --10.83B |
Operating income | 7.12%9.98B | 28.52%20.21B | 38.67%9.32B | -6.80%15.72B | 6.72B | 55.72%16.87B | 10.83B |
Cost of sales | -6.53%-9.36B | -27.84%-19.13B | -38.92%-8.79B | 8.38%-14.96B | ---6.33B | -60.25%-16.33B | ---10.19B |
Operating expenses | -6.53%-9.36B | -27.84%-19.13B | -38.92%-8.79B | 8.38%-14.96B | -6.33B | -60.25%-16.33B | -10.19B |
Gross profit | 16.94%617.51M | 41.91%1.08B | 34.71%528.04M | 41.53%759.25M | 391.98M | -16.34%536.44M | 641.22M |
Selling expenses | 7.32%-118.94M | -32.32%-257.33M | -39.77%-128.34M | -10.00%-194.47M | ---91.82M | -36.85%-176.79M | ---129.18M |
Administrative expenses | -20.73%-40.47M | -16.84%-79.77M | 3.62%-33.52M | 10.10%-68.28M | ---34.78M | 4.84%-75.95M | ---79.81M |
Research and development expenses | -51.28%-11.26M | -29.09%-17.47M | -47.08%-7.44M | -26.21%-13.53M | ---5.06M | -44.53%-10.72M | ---7.42M |
Impairment and provision | 55.18%-238K | -110.67%-1.08M | -110.68%-531K | 176.43%10.09M | --4.97M | -238.36%-13.2M | --9.54M |
-Other impairment is provision | 55.18%-238K | -110.67%-1.08M | -110.68%-531K | 176.43%10.09M | --4.97M | -238.36%-13.2M | --9.54M |
Special items of operating profit | -78.32%-344.31M | -84.13%-353.57M | -95.79%-193.09M | -291.54%-192.03M | ---98.62M | 179.19%100.26M | ---126.6M |
Operating profit | -38.05%102.29M | 22.33%368.25M | -0.93%165.12M | -16.39%301.03M | 166.67M | 16.99%360.04M | 307.74M |
Financing cost | -13.78%-35.43M | -11.02%-63.13M | 9.74%-31.14M | 11.37%-56.87M | ---34.5M | 11.65%-64.16M | ---72.62M |
Earning before tax | -50.09%66.86M | 24.96%305.11M | 1.37%133.98M | -17.48%244.16M | 132.17M | 25.84%295.87M | 235.12M |
Tax | 47.80%-14.61M | -12.99%-71.64M | 9.97%-27.99M | 11.17%-63.41M | ---31.09M | -17.74%-71.38M | ---60.62M |
After-tax profit from continuing operations | -50.70%52.25M | 29.16%233.47M | 4.85%105.99M | -19.48%180.76M | 101.08M | 28.66%224.5M | 174.49M |
Earning after tax | -50.70%52.25M | 29.16%233.47M | 4.85%105.99M | -19.48%180.76M | 101.08M | 28.66%224.5M | 174.49M |
Minority profit | 164.78%4.82M | 4,588.41%3.1M | 285.59%1.82M | -101.78%-69K | --472K | 965.93%3.88M | --364K |
Profit attributable to shareholders | -54.46%47.43M | 27.40%230.38M | 3.53%104.17M | -18.04%180.83M | 100.61M | 26.70%220.62M | 174.13M |
Basic earnings per share | -53.33%0.21 | 26.25%1.01 | 0.00%0.45 | -18.37%0.8 | 0.45 | 27.27%0.98 | 0.77 |
Diluted earnings per share | -53.33%0.21 | 26.25%1.01 | 0.00%0.45 | -18.37%0.8 | 0.45 | 27.27%0.98 | 0.77 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data